THE MORTALITY OF DENGUE FEVER IN CARDIAC AND NON-CARDIAC PATIENTS
DOI:
https://doi.org/10.4238/cxmj4920Keywords:
Dengue fever, cardiac comorbidity, myocarditis, Mortality, Patients.Abstract
Background: Dengue fever remains a major public health problem in tropical and subtropical regions, including Pakistan.
Objective: To determine the frequency of cardiac patients presenting with dengue fever and to compare the mortality rates of dengue fever in cardiac and non-cardiac patients.
Methods: This descriptive case series was conducted at October 2025 to January 2026. A total of 200 patients diagnosed with dengue fever (confirmed by NS1 antigen or IgM/IgG ELISA) were included. Patients were divided into two groups: those with pre-existing cardiac conditions (cardiac group) and those without (non-cardiac group). Data were collected prospectively, including demographics, dengue severity, treatment, and outcomes.
Results: Out of the 200 patients, 62 (31%) had pre-existing cardiac conditions, and 138 (69%) were non-cardiac. The mean age was significantly higher in cardiac patients (59.2 ± 10.1 years) than in non-cardiac patients (48.1 ± 12.9 years; p < 0.001). Severe dengue occurred in 56.4% of cardiac patients versus 36.2% of non-cardiac patients (p = 0.01). The overall mortality rate was 11%, with deaths significantly more frequent among cardiac patients (21%) compared to non-cardiac patients (6.5%) (p = 0.004). Multivariate logistic regression identified cardiac disease (OR = 3.92; 95% CI: 1.45–10.57; p = 0.007), severe dengue (OR = 4.28; 95% CI: 1.76–10.36; p = 0.001), and age > 55 years (OR = 2.17; 95% CI: 1.01–4.67; p = 0.046) as independent predictors of mortality.
Conclusion: It is concluded that dengue fever patients with pre-existing cardiac disease have a significantly higher mortality rate than those without cardiac involvement. Cardiac dysfunction, severe dengue, and advanced age were the strongest predictors of fatal outcomes.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

